-
Product Insights
NewExo Alpha Sialidase – Drugs In Development, 2024
The Exo Alpha Sialidase pipeline drugs market research report outlays comprehensive information on the Exo Alpha Sialidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, and Oncology which include indications of Influenza A Virus, H1N1 Subtype Infections, Influenzavirus B Infections, Breast Cancer, and Colorectal Cancer. It also reviews key players involved in Exo Alpha Sialidase...
-
Product Insights
NewBiological Dynamics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Biological Dynamics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Biological Dynamics Inc (Biological Dynamics) operates as a molecular diagnostics company. The company’s proprietary lab-on-a-chip (LOC) platform, Verita utilizes AC electrokinetics (ACE) technology for isolation of nanoparticles and macromolecules from biofluids includes whole blood, plasma and serum. It also develops lung assay to support treatment response in for patients with non-small cell lung cancer. Biological Dynamics utilizes its platform...
-
Sector Analysis
NewBody Armor and Personal Protection Market Trends and Analysis by Type, Region, and Segment Forecast to 2033
Accessing the in-depth insights from the ‘Body Armor and Personal Protection’ report can help: Understand the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments Identify competitors' capabilities to stay ahead in the market Identify segments and get an understanding of various stakeholders across different stages of the entire value chain Anticipate changes in demand and adjust the business development strategies Identify potential regions and countries for growth opportunities...
-
Thematic Analysis
Cloud Computing – Thematic Intelligence
Cloud Computing Thematic Report Overview The cloud services sector competes to provide the best artificial intelligence (AI) platforms and services, partly catalyzed by the emergence of generative AI. AI is now central to the cloud services market, from developing custom chips and supporting workloads and providing the models and tools necessary to develop AI-enabled solutions. The Cloud Computing  thematic intelligence report provides an overview of the cloud computing theme. It identifies the key trends impacting the growth of the theme...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EXO-CD24 in Acute Respiratory Distress Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EXO-CD24 in Acute Respiratory Distress Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EXO-CD24 in Acute Respiratory Distress Syndrome Drug Details: EXO-CD24 is...
-
Product Insights
Ultrasound Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ultrasound Systems Pipeline Market Report Overview Ultrasound Systems are devices that make use of sound waves of high frequency to produce images of structures inside the body. Most of the devices use Sonar principles and are placed outside while in a few cases, they are even placed inside of the body. 2D Ultrasound Systems, 3D Ultrasound Systems, Real-Time 3D Ultrasound Systems, and Hand Held Ultrasound (HHU) Systems are tracked under this category. The Ultrasound Systems pipeline market research report provides...
-
Product Insights
NewBronchopulmonary Dysplasia – Drugs In Development, 2024
Empower your strategies with our Bronchopulmonary Dysplasia – Drugs In Development, 2024 report and make more profitable business decisions. Bronchopulmonary dysplasia (BPD) is a form of chronic lung disease that develops in preterm neonates treated with oxygen and positive-pressure ventilation. Symptoms of BPD include tachypnea, tachycardia, increased respiratory effort (with retractions, nasal flaring, and grunting), and bluish skin color. Risk factors include congenital heart disease and severe respiratory or lung infection; premature babies who have a low birth weight seem to...
-
Product Insights
Orthotic Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Orthotic Devices Pipeline Market Report Overview Orthotic Devices are used for supporting an injured part in both pre- and post-operative procedures. The orthotic devices pipeline market research report provides a comprehensive understanding of the pipeline products and their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Orthopedic Braces and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mesenchymal Stem Cells-Derived Exosomes in Acute Respiratory Distress Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mesenchymal Stem Cells-Derived Exosomes in Acute Respiratory Distress Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Mesenchymal Stem Cells-Derived Exosomes in Acute Respiratory Distress...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mesenchymal Stem Cells-Derived Exosomes in Dermatomyositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mesenchymal Stem Cells-Derived Exosomes in Dermatomyositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Mesenchymal Stem Cells-Derived Exosomes in Dermatomyositis Drug Details: The drug candidate...